엑소좀 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 엑소좀 유형별, 공급원별, 치료법별, 용도별, 최종사용자별, 지역별, 경쟁별(2019-2029년)
Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Exosome Type, By Source, By Therapy, By Application, By End User, By Region and Competition, 2019-2029F
상품코드 : 1463913
리서치사 : TechSci Research
발행일 : 2024년 04월
페이지 정보 : 영문 180 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,500 ₩ 6,483,000
Unprintable PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 5,500 ₩ 7,924,000
PDF and Excel (Multi-User License) help
PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.
US $ 8,000 ₩ 11,526,000
PDF and Excel (Custom Research License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 엑소좀 치료 시장은 2023년에 3,163만 달러로 평가되며, 2029년까지의 CAGR은 41.34%로, 예측 기간 중 눈부신 성장이 예측됩니다.

세계의 엑소좀 치료 시장은 세포 간 소통에서 엑소좀의 중요한 역할과 잠재적인 치료적 활용 가능성에 대한 인식이 높아짐에 따라 강력한 성장세를 보이고 있습니다. 세포에서 방출되는 작은 소포인 엑소좀은 단백질, 핵산, 지질과 같은 생리활성 분자를 세포 간 전달하여 다양한 생리적, 병리학적 과정에 영향을 미치는 능력으로 주목받고 있습니다.

시장 성장의 주요 원동력은 암, 심혈관 질환, 신경 퇴행성 질환, 염증성 질환과 같은 만성질환의 전 세계 유병률 증가입니다. 엑솜이 암의 진행과 전이에 관여하기 때문에 암 부문은 엑솜 치료 시장에 큰 기여를 할 것으로 예상됩니다. 약물전달, 면역 요법 등 엑소좀을 이용한 암 치료 연구가 활발히 진행되고 있습니다.

신경퇴행성 질환은 엑소좀이 혈액뇌장벽을 통과할 수 있는 능력을 가지고 있으므로 엑소좀 치료의 유망한 분야이기도 합니다. 따라서 엑소좀은 알츠하이머병이나 파킨슨병과 같은 질병을 치료할 수 있는 잠재력을 가지고 있습니다. 또한 엑소좀은 재생의학 분야에서 조직 복구 및 재생에 대한 역할이 연구되고 있습니다. 엑소좀 기반 치료법의 개발 및 상용화를 촉진하기 위해 제약사, 바이오테크 기업 및 연구기관 간의 공동연구가 증가하고 있는 것이 시장 특징입니다. 유망한 전임상 및 초기 임상시험 결과를 바탕으로 연구개발 활동에 대한 투자가 증가하고 있습니다.

엑솜의 분리, 정제 및 특성 분석 방법의 기술적 진보가 시장 성장에 기여하고 있습니다. 업계 기업은 엑소좀 기반 치료를 위한 확장 가능하고 비용 효율적인 제조 공정 개발에 주력하고 있습니다. 또한 엑소좀의 생물학 및 화물 적재 기술에 대한 이해는 치료 개입의 정확성과 효능을 향상시키는 데 기여하고 있습니다. 시장은 분리 및 특성화 방법의 표준화, 규제적 고려사항, 대규모 생산의 복잡성 등의 과제에 직면해 있습니다. 규제기관은 엑소좀을 이용한 치료법 개발 및 승인에 대한 명확한 가이드라인을 제공하기 위해 노력하고 있으며, 산업계와 규제기관의 협력 관계의 중요성을 강조하고 있습니다.

세계 엑소좀 치료 시장은 질병 치료에서 엑소좀의 변혁적 잠재력으로 인해 크게 성장하고 있습니다. 지속적인 연구를 통해 시장은 더욱 확대되어 환자에게 새로운 전망을 제공하고 엑소좀 기반 치료가 미래 의료의 중요한 측면으로 자리 잡을 가능성이 높습니다.

주요 시장 성장 촉진요인

만성질환의 유병률 증가

조사와 기술 혁신 증가

주요 시장 과제

확장성 및 표준화

임상시험의 과제

이해와 교육 부족

주요 시장 동향

번역 나노의약을 위한 인공 엑소좀

파트너십 및 공동 연구 증가

엑소좀 치료제 시장 투자 증가

진단 용도 확대

부문별 인사이트

엑소좀 유형별 인사이트

공급원별 인사이트

지역별 인사이트

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 엑소좀 치료 시장 전망

제5장 아시아태평양의 엑소좀 치료 시장 전망

제6장 유럽의 엑소좀 치료 시장 전망

제7장 북미의 엑소좀 치료 시장 전망

제8장 남미의 엑소좀 치료 시장 전망

제9장 중동 및 아프리카의 엑소좀 치료 시장 전망

제10장 시장 역학

제11장 시장 동향과 개발

제12장 세계의 엑소좀 치료 시장 SWOT 분석

제13장 Porter's Five Forces 분석

제14장 경쟁 구도

제15장 전략적 제안

제16장 TechSci Research 소개·면책사항

KSA
영문 목차

영문목차

Global Exosome Therapeutics Market was valued at USD 31.63 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 41.34% through 2029.Global Exosome Therapeutics Market is experiencing robust growth, fueled by the increasing recognition of exosomes' crucial role in intercellular communication and their potential therapeutic uses. Exosomes, tiny vesicles released by cells, are gaining attention for their ability to transfer bioactive molecules like proteins, nucleic acids, and lipids between cells, influencing various physiological and pathological processes.

A primary driver for market growth is the escalating prevalence of chronic diseases globally, such as cancer, cardiovascular diseases, neurodegenerative disorders, and inflammatory conditions. Exosomes offer a novel approach by delivering therapeutic cargo to specific cells, enhancing treatment effectiveness while reducing side effects.The oncology sector is expected to significantly contribute to the exosome therapeutics market due to exosomes' involvement in cancer progression and metastasis. There's active exploration of exosome-based therapies for cancer treatment, including drug delivery and immunotherapy.

Neurodegenerative diseases present another promising area for exosome therapeutics, given exosomes' ability to cross the blood-brain barrier. This positions them as potential vehicles for treating conditions like Alzheimer's and Parkinson's disease. Additionally, exosomes are being investigated for their role in tissue repair and regeneration in the field of regenerative medicine.The market is characterized by increasing collaborations between pharmaceutical companies, biotechnology firms, and research institutions to expedite the development and commercialization of exosome-based therapies. Investment in research and development activities is rising, driven by promising preclinical and early clinical results.

Technological advancements in exosome isolation, purification, and characterization methods are contributing to market growth. Industry players are focusing on developing scalable and cost-effective manufacturing processes for exosome-based therapeutics. Furthermore, understanding exosome biology and cargo loading techniques is improving the precision and efficacy of therapeutic interventions.The market faces challenges such as standardization of isolation and characterization methods, regulatory considerations, and complexities in large-scale production. Regulatory agencies are working on providing clearer guidelines for exosome-based therapy development and approval, highlighting the importance of collaborations between industry and regulatory bodies.

Global Exosome Therapeutics Market is witnessing significant growth driven by the transformative potential of exosomes in disease treatment. Continued research is likely to expand the market further, offering new prospects for patients and establishing exosome-based therapies as a crucial aspect of future medicine.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

Chronic diseases like cardiovascular diseases, diabetes, and cancer profoundly impact individuals' quality of life and life expectancy globally. Exosomes, small vesicles secreted by cells, are gaining considerable attention for their potential in treating these conditions. The rising prevalence of chronic diseases is propelling the global exosome therapeutics market to new heights.

Exosomes play a crucial role in influencing the immune system, making them valuable tools in autoimmune disease treatment and cancer immunotherapy. They can either suppress or stimulate immune responses, depending on the desired therapeutic outcome, thus driving the expansion of the global exosome therapeutics market.Exosome therapeutics utilize these tiny vesicles' potential to address various chronic diseases. Researchers have identified exosomes as promising carriers for delivering therapeutic cargo directly to affected cells, tissues, and organs. This approach offers several advantages over traditional drug delivery methods, including improved bioavailability, reduced toxicity, and the ability to target specific cells or tissues. The growing body of research in exosome therapeutics reveals their potential in addressing a wide range of chronic diseases, thereby fueling rapid growth in the exosome therapeutics market.

Cancer remains a significant challenge in the healthcare sector. According to the World Cancer Research Fund International, there were an estimated 18.1 million cancer cases globally in 2020, with 9.3 million in males and 8.8 million in females. Exosome therapeutics show considerable potential in both cancer diagnosis and treatment. Exosomes can carry valuable diagnostic markers for early cancer detection. Additionally, researchers are actively exploring exosomes as drug delivery vehicles for targeted cancer therapies. These nanocarriers can enhance the specificity and efficacy of cancer treatment while minimizing damage to healthy tissues, thereby contributing to the growth of the global exosome therapeutics market.

Rising Research and Innovation

The growth of the global exosome therapeutics market is significantly driven by the increasing focus on research and development. Scientists and medical professionals are continuously uncovering the potential applications of exosome-based therapies, leading to a surge in market growth.Pharmaceutical companies and academic institutions are making substantial investments in clinical studies and trials to assess the safety and efficacy of exosome-based therapies across various medical conditions, including neurodegenerative diseases, cancer, and cardiovascular disorders.

Advanced technologies for isolating, purifying, and characterizing exosomes have facilitated more precise and effective exosome-based therapies, contributing to market expansion.Researchers are also innovating new delivery methods to ensure exosomes reach their target tissues in sufficient quantities, such as through intravenous injection, driving further growth in the global exosome therapeutics market.

Moreover, exosomes are being explored as potential treatments for inflammatory diseases like Crohn's disease and ulcerative colitis, where they are used to deliver anti-inflammatory drugs and other therapeutic agents to sites of inflammation, bolstering overall market growth.Continued research into how exosomes interact with cells and distribute throughout the body is crucial for developing safe and effective therapies, thus further contributing to the expansion of the global exosome therapeutics market.

Key Market Challenges

Scalability and Standardization

Scaling up exosome production to meet the rising demand for therapeutics poses a significant challenge. While laboratories can generate exosomes in small quantities, achieving industrial-scale manufacturing is a different endeavor. The production process entails cell culture, exosome harvesting, and final product purification.

Developing standardized methods for characterizing exosomes and their cargo is of utmost importance. The lack of consistent protocols for exosome analysis hampers the assessment of their quality, potency, and safety. Furthermore, ensuring batch-to-batch consistency of exosome products is challenging due to their inherent heterogeneity.

Clinical Trial Challenges

Clinical trials play a crucial role in demonstrating the safety and efficacy of new drugs. However, designing and conducting clinical trials for exosome therapeutics present several challenges. One such challenge is the inherent complexity and heterogeneity of exosomes, making it difficult to standardize their production and establish reliable methods for measuring their activity.

When designing clinical trials for exosome therapeutics, careful consideration must be given to endpoints, patient populations, and treatment regimens. Selecting appropriate biomarkers and surrogate endpoints for diseases treated with exosomes can be particularly challenging. Additionally, determining the optimal dosing and treatment schedules is of utmost importance, although it can be a complex task.

Lack of Understanding and Education

Many scientists and healthcare professionals have limited knowledge of the intricacies of exosome biology and their potential therapeutic applications. This knowledge gap often results in skepticism and a hesitance to allocate time and resources to exosome research. Bridging this gap through comprehensive education and training programs is crucial for cultivating interest and understanding among scientists and clinicians.

Furthermore, patients and the general public lack awareness of exosome-based therapies and their potential benefits. Well-informed patients play a vital role in driving demand for these treatments and increasing participation in clinical trials. Implementing effective patient education campaigns is an essential step in closing this information gap.

Key Market Trends

Artificial Exosomes for Translational Nanomedicine

In recent times, artificial exosomes have been gaining prominence within the field of nanobiotechnology as a means to address the constraints associated with natural exosomes. Key categories of artificial exosomes encompass 'nanovesicles (NVs),' 'exosome-mimetic (EM),' and 'hybrid exosomes (HE),' which are generated through top-down, bottom-up, and biohybrid techniques, respectively. Artificial exosomes represent potent substitutes for natural exosomes in the realm of drug delivery. Artificial exosomes can be equipped with diagnostic markers, enabling them to serve as both drug delivery vehicles and diagnostic tools. This dual function enhances patient care by monitoring disease progression and treatment response in real-time.

Rising Partnerships and Collaborations

Numerous companies and research institutions are forging partnerships to combine their expertise in various facets of exosome research and development. The field of exosome research and therapeutic development demands substantial investments. Collaborations provide access to financial resources, empowering smaller companies and startups to compete with more established players. Public-private partnerships and academic-industry collaborations have played a pivotal role in securing funding for research and clinical trials. In August 2023, Evox Therapeutics officially disclosed their research findings, unveiling the discovery of novel exosome scaffold proteins that significantly enhance the efficient loading of drugs into exosomes, thereby serving a crucial purpose in therapeutics

Growing Investment in Exosome Therapeutics Market

Exosome therapeutics offer a wide range of potential applications, spanning from treating degenerative diseases to enhancing drug delivery and diagnostics. This versatility has garnered interest from investors seeking diverse investment opportunities. The growing understanding of exosome biology and their role in health and disease has instilled confidence in the therapeutic potential of exosomes. Encouraging preclinical and clinical studies have established a robust scientific foundation for investment. Stakeholders in the industry, including academic institutions, industry leaders, and startups, are forming strategic collaborations and partnerships to propel research and development in the exosome therapeutics field. These alliances not only facilitate capital flow but also foster knowledge exchange and technological advancements.

Expanding Diagnostic Applications

Exosomes contain a rich repository of data regarding the source cells, encompassing details about their genetic composition and protein constituents. This makes exosomes valuable diagnostic tools for various cancers. Beyond diagnostics, researchers are exploring exosomes as potential drug delivery vehicles for cancer therapies, improving precision and reducing side effects. The study of exosomes in neurodegenerative disorders, such as Alzheimer's and Parkinson's disease, has unlocked new insights. Exosomes carry toxic proteins and other molecules implicated in these conditions, which open avenues for early diagnosis and therapeutic intervention

Segmental Insights

Exosome Type Insights

Basedon the Exosome Type, the global exosome therapeutics market can be classified into two types based on exosome type: Natural and Hybrid. Natural exosomes currently dominate the market due to their lower likelihood of triggering an immune response when used therapeutically. This is because they are derived from the patient's own cells or from a donor source. Moreover, natural exosomes play crucial roles in various biological processes and are currently under extensive research to uncover their potential applications. As a result, the market is expected to witness significant growth in the projected period.

Source Insights

According to the source, the global exosome therapeutics market can be categorized into mesenchymal stem cells, blood, body fluids, and others. Mesenchymal stem cells dominate the global exosome therapeutics market due to their demonstrated regenerative and anti-inflammatory properties in both preclinical and clinical studies. These exosomes derived from mesenchymal stem cells are currently under investigation for their potential in treating a wide range of conditions, including tissue injuries, neurological disorders, and inflammatory diseases.

Regional Insights

Based on Region, the global exosome therapeutics market can be segmented into North America, Asia Pacific, Europe, Middle East Africa and South America. North America dominates the global exosome therapeutics market due to the surge in clinical trials in the region involving exosome-based therapies, covering a wide range of medical conditions. This progress in clinical research has led to the commercialization of several exosome therapeutics, further establishing North America's dominance in the global market.

Key Market Players

Aethlon Medical, Inc.

AEGLE Therapeutics Corporation

Anjarium Biosciences AG

Exogenus Therapeutics SA

Lonza Group AG

Capricor Therapeutics Inc

Avalon GloboCare Corp.

Stem Cell Medicine Ltd.

Evox Therapeutics Limited.

EV Therapeutics

Report Scope:

In this report, the Global Exosome Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Exosome Therapeutics Market,By Exosome Type:

Exosome Therapeutics Market,By Source:

Exosome Therapeutics Market,By Therapy:

Exosome Therapeutics Market,By Application:

Exosome Therapeutics Market,By End User:

Exosome Therapeutics Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Exosome Therapeutics Market.

Available Customizations:

Global Exosome Therapeutics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

2.Research Methodology

3.Executive Summary

4.Global Exosome Therapeutics Market Outlook

5.Asia Pacific Exosome Therapeutics Market Outlook

6.Europe Exosome Therapeutics Market Outlook

7.North America Exosome Therapeutics Market Outlook

8.South America Exosome Therapeutics Market Outlook

9.Middle East and Africa Exosome Therapeutics Market Outlook

10.Market Dynamics

11.Market Trends Developments

12.Global Exosome Therapeutics Market: SWOT Analysis

13.Porter's Five Forces Analysis

14.Competitive Landscape

15.Strategic Recommendations

16.About Us Disclaimer

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기